Rankings
▼
Calendar
IMA Q1 2025 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena
IMA
ImageneBio Inc
$67M
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$4M
Operating Income
-$11M
Net Income
-$9M
EPS (Diluted)
$-0.18
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$11M
Stock-Based Comp.
$904,000
Balance Sheet
Total Assets
$131M
Total Liabilities
$13M
Stockholders' Equity
$118M
Cash & Equivalents
$37M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$4M
-$10M
+61.5%
Operating Income
-$11M
-$18M
+40.8%
Net Income
-$9M
-$16M
+46.6%
← Q4 2024
All Quarters
Q2 2025 →